Cirrhotic rat liver: Reference to transporter activity and morphologic changes in bile canaliculi - Gadoxetic acid-enhanced MR imaging

Radiology

Volumn 256, Issue 3, 2010, Pages 767-773

  Tsuda, Natsuko ^a   Matsui, Osamu ^b  

^a Bayer Yakuhin ^*  (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOXETIC ACID; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTER 1; THIOACETAMIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INTRAHEPATIC BILE DUCT; LASER CAPTURE MICRODISSECTION; LIVER CIRRHOSIS; MALE; MICROVILLUS; MORPHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; UPREGULATION;

ANIMALS; CONTRAST MEDIA; GADOLINIUM DTPA; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER CIRRHOSIS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MALE; MICRODISSECTION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STATISTICS, NONPARAMETRIC; THIOACETAMIDE;

EID: 77956112516     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10092065     Document Type: Article

References (26)

1. Kim SH, Kim SH, Lee J, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009;192(6):1675-1681.
2. Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009;44(suppl 19):112-118.
3. Kudo M. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 2008;75(suppl 1): 1-12.
4. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009;49(2):658-664. [Published correction appears in Hepatology 2009;49(3):1058.]
5. Zech CJ, Reiser MF, Herrmann KA. Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art. Dig Dis 2009;27(2):114-124.
6. Matsui O, Gabata T, Kobayashi S, et al. Imaging of multistep human hepatocarcinogenesis. Hepatol Res 2007;37(suppl 2):S200-S205.
7. van den Bos IC, Hussain SM, Terkivatan TT, Zondervan PE, de Man RA. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging 2006;24(5):1071-1080.
8. Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 2004;47(3-5): 271-276.
9. Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodiumenhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45(3):133-141.
10. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L. Consensus report of the 2nd international forum for liver MRI. Eur Radiol 2009;19(suppl 5):S975-S989.
11. Frericks BB, Loddenkemper C, Huppertz A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 2009;193(4):1053-1060.
12. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D. Contrastenhanced MR cholangiography with Gd-EOBDTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008;18(8):1577-1586.
13. Pascolo L, Petrovic S, Cupelli F, et al. Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 2001;282(1):60-66.
14. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 1999;290(1):153-157. (Pubitemid 29302315)
15. Pascolo L, Cupelli F, Anelli PL, et al. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 1999; 257(3):746-752.
16. Stasiak A, Fogel WA. High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment. J Physiol Pharmacol 2008; 59(1):101-114.
17. Constantinou MA, Theocharis SE, Mikros E. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicol Appl Pharmacol 2007;218(1):11-19.
18. Kang JS, Wanibuchi H, Morimura K, et al. Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats. Toxicol Sci 2005;85(1):720-726. (Pubitemid 40614302)
19. Yeh CN, Maitra A, Lee KF, Jan YY, Chen MF. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis 2004;25(4):631-636.
20. Baiocchi L, Tisone G, Russo MA, et al. TUDCA prevents cholestasis and canali cular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway. Transpl Int 2008;21(8):792-800.
21. Li GX, Pei QL, Gao Y, et al. Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arseniteinduced hepatic dysfunction in rats. Exp Toxicol Pathol 2007;58(6):447-453.
22. Takakuwa Y, Kokai Y, Sasaki K, et al. Bile canalicular barrier function and expression of tight-junctional molecules in rat hepatocytes during common bile duct ligation. Cell Tissue Res 2002;307(2):181-189. (Pubitemid 34158530)
23. Cutrin JC, Cantino D, Biasi F, et al. Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology 1996;24(5): 1053-1057.
24. Ogawa H. Scanning electron microscopy of rat liver hyperplastic nodules induced by diethylnitrosamine. Scan Electron Microsc 1982(pt 4):1793-1798.
25. Shimamura T, Hayase K, Wang JC, Cotton J, Savoca VJ. Structural alterations of the liver induced by N,N'-diacethylbenzidine: a new model of cirrhosis. Arch Pathol Lab Med 1979;103(7):327-330. (Pubitemid 10248812)
26. Ni Y, Marchal G, Lukito G, Yu J, Mühler A, Baert AL. MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings. Radiology 1994;190(3):753-758.